Except for historical information contained herein, the information on this website site contains forward-looking statements that are subject to risks and uncertainties that may cause actual results to differ materially from the results discussed in the forward-looking statements, particularly those risks and uncertainties inherent in the process of discovering, developing and commercializing medical devices that are safe and effective for use as human therapeutics. Factors that may cause such a difference include risks related to Cardiac Dimensions Pty. Ltd. and subsidiaries (collectively “Cardiac Dimensions”) limited operating history, risks associated with conducting and completing Cardiac Dimensions’ clinical trials, the risk that the results obtained in one clinical trial will not be obtained in a subsequent clinical trial, the risk that the safety or efficacy results of a clinical trial will not support an future development of that product candidate, the risks that preclinical development efforts will not generate results that warrant further development of a product candidate, the uncertainty of Cardiac Dimensions’ future access to capital, the failure by Cardiac Dimensions’ to secure and maintain relationships with collaborators, and Cardiac Dimensions’ dependence on the efforts of third parties, dependence on management, and dependence on intellectual property.
Join our mailing list for invitations to studies along with company announcements.
*NOTE: The Carillon Mitral Contour System has received CE Mark (0344) and is available for sale in Europe and other countries that recognize CE Mark.
CAUTION: Investigational Device. Limited by United States law to investigational use.